Literature DB >> 15820333

Further study of a genetic association between the CLDN5 locus and schizophrenia.

Lin Ye, Zuyue Sun, Lin Xie, Shuzheng Liu, Guizhi Ju, Jieping Shi, Yaqin Yu, Xuan Zhang, Jun Wei, Qi Xu, Yan Shen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15820333     DOI： 10.1016/j.schres.2004.11.003

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  14 in total

1.  Transmission disequilibrium test provides evidence of association between promoter polymorphisms in 22q11 gene DGCR14 and schizophrenia.

Authors:  H Wang; S Duan; J Du; X Li; Y Xu; Z Zhang; Y Wang; G Huang; G Feng; L He
Journal:  J Neural Transm (Vienna)       Date:  2006-01-25       Impact factor: 3.575

Review 2.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 3.  Environmental Exposures and Neuropsychiatric Disorders: What Role Does the Gut-Immune-Brain Axis Play?

Authors:  Shannon Delaney; Mady Hornig
Journal:  Curr Environ Health Rep       Date:  2018-03

Review 4.  Analyses of the associations between the genes of 22q11 deletion syndrome and schizophrenia.

Authors:  Tadao Arinami
Journal:  J Hum Genet       Date:  2006-09-13       Impact factor: 3.172

Review 5.  The Role of Brain Microvascular Endothelial Cell and Blood-Brain Barrier Dysfunction in Schizophrenia.

Authors:  Sovannarath Pong; Rakesh Karmacharya; Marianna Sofman; Jeffrey R Bishop; Paulo Lizano
Journal:  Complex Psychiatry       Date:  2020-09-14

6.  Supportive evidence for reduced expression of GNB1L in schizophrenia.

Authors:  Hiroki Ishiguro; Minori Koga; Yasue Horiuchi; Emiko Noguchi; Miyuki Morikawa; Yoshimi Suzuki; Makoto Arai; Kazuhiro Niizato; Shyuji Iritani; Masanari Itokawa; Toshiya Inada; Nakao Iwata; Norio Ozaki; Hiroshi Ujike; Hiroshi Kunugi; Tsukasa Sasaki; Makoto Takahashi; Yuichiro Watanabe; Toshiyuki Someya; Akiyoshi Kakita; Hitoshi Takahashi; Hiroyuki Nawa; Tadao Arinami
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

7.  IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia.

Authors:  Emily G Severance; Kristin L Gressitt; Armin Alaedini; Cathrin Rohleder; Frank Enning; J Malte Bumb; Juliane K Müller; Emanuel Schwarz; Robert H Yolken; F Markus Leweke
Journal:  Brain Behav Immun       Date:  2014-09-20       Impact factor: 7.217

8.  Analysis of TBX1 variation in patients with psychotic and affective disorders.

Authors:  Birgit H Funke; Todd Lencz; Christine T Finn; Pamela DeRosse; G David Poznik; Alex M Plocik; John Kane; John Rogus; Anil K Malhotra; Raju Kucherlapati
Journal:  Mol Med       Date:  2007 Jul-Aug       Impact factor: 6.354

9.  Disruption of the blood-brain barrier in 22q11.2 deletion syndrome.

Authors:  Alexis M Crockett; Sean K Ryan; Adriana Hernandez Vásquez; Caroline Canning; Nickole Kanyuch; Hania Kebir; Guadalupe Ceja; James Gesualdi; Elaine Zackai; Donna McDonald-McGinn; Angela Viaene; Richa Kapoor; Naïl Benallegue; Raquel Gur; Stewart A Anderson; Jorge I Alvarez
Journal:  Brain       Date:  2021-06-22       Impact factor: 13.501

10.  Expression of the G72/G30 gene in transgenic mice induces behavioral changes.

Authors:  L Cheng; E Hattori; A Nakajima; N S Woehrle; M D Opal; C Zhang; K Grennan; S C Dulawa; Y-P Tang; E S Gershon; C Liu
Journal:  Mol Psychiatry       Date:  2013-01-22       Impact factor: 15.992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.